Your browser doesn't support javascript.
Persistent Symptoms and Sequelae After Severe Acute Respiratory Syndrome Coronavirus 2 Infection Not Requiring Hospitalization: Results From Testing Denmark, a Danish Cross-sectional Survey.
van Wijhe, Maarten; Fogh, Kamille; Ethelberg, Steen; Karmark Iversen, Kasper; Nielsen, Henrik; Østergaard, Lars; Andersen, Berit; Bundgaard, Henning; Jørgensen, Charlotte S; Scharff, Bibi F Ss; Ellermann-Eriksen, Svend; Johansen, Isik S; Fomsgaard, Anders; Grove Krause, Tyra; Wiese, Lothar; Fischer, Thea K; Mølbak, Kåre; Benfield, Thomas; Folke, Fredrik; Lippert, Freddy; Ostrowski, Sisse R; Koch, Anders; Erikstrup, Christian; Vangsted, Anne-Marie; Sørensen, Anna Irene Vedel; Ullum, Henrik; Skov, Robert Leo; Simonsen, Lone; Nielsen, Susanne Dam.
  • van Wijhe M; Department of Science and Environment, Roskilde University, Roskilde, Denmark.
  • Fogh K; Department of Cardiology, Copenhagen University Hospital, Herlev and Gentofte, Denmark.
  • Ethelberg S; Department of Emergency Medicine, Copenhagen University Hospital, Herlev and Gentofte, Denmark.
  • Karmark Iversen K; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Nielsen H; Statens Serum Institut, Copenhagen, Denmark.
  • Østergaard L; Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
  • Andersen B; Department of Cardiology, Copenhagen University Hospital, Herlev and Gentofte, Denmark.
  • Bundgaard H; Department of Emergency Medicine, Copenhagen University Hospital, Herlev and Gentofte, Denmark.
  • Jørgensen CS; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Scharff BFS; Department of Infectious Diseases, Aalborg University Hospital, Aalborg, Denmark.
  • Ellermann-Eriksen S; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
  • Johansen IS; Statens Serum Institut, Copenhagen, Denmark.
  • Fomsgaard A; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.
  • Grove Krause T; Statens Serum Institut, Copenhagen, Denmark.
  • Wiese L; University Research Clinic for Cancer Screening, Randers Regional Hospital, Randers, Denmark.
  • Fischer TK; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Mølbak K; Department of Cardiology, Copenhagen University Hospital, Rigshospitalet, Denmark.
  • Benfield T; Statens Serum Institut, Copenhagen, Denmark.
  • Folke F; Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Denmark.
  • Lippert F; Statens Serum Institut, Copenhagen, Denmark.
  • Ostrowski SR; Department of Clinical Microbiology, Aarhus University Hospital, Aarhus, Denmark.
  • Koch A; Department of Infectious Diseases, Odense University Hospital, Odense, Denmark.
  • Erikstrup C; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Vangsted AM; Statens Serum Institut, Copenhagen, Denmark.
  • Sørensen AIV; Statens Serum Institut, Copenhagen, Denmark.
  • Ullum H; Department of Infectious Diseases, Zealand University Hospital, Roskilde, Denmark.
  • Skov RL; Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
  • Simonsen L; Department of Clinical Research, North Zealand Hospital, Hillerød, Denmark.
  • Nielsen SD; Statens Serum Institut, Copenhagen, Denmark.
Open Forum Infect Dis ; 10(1): ofac679, 2023 Jan.
Article in English | MEDLINE | ID: covidwho-2190086
ABSTRACT

Background:

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with persistent symptoms ("long COVID"). We assessed the burden of long COVID among nonhospitalized adults with polymerase chain reaction (PCR)-confirmed SARS-CoV-2 infection.

Methods:

In the fall of 2020, a cross-sectional survey was performed in the adult Danish general population. This included a self-administered point-of-care test for SARS-CoV-2 antibodies, the Short Form Health Survey (SF-12), and coronavirus disease 2019 (COVID-19)-associated symptom questions. Nonhospitalized respondents with a positive SARS-CoV-2 PCR test ≥12 weeks before the survey (cases) were matched (110) to seronegative controls on age, sex, and body mass index. Propensity score-weighted odds ratios (ORs) and ORs for risk factors were estimated for each health outcome.

Results:

In total, 742 cases and 7420 controls were included. The attributable risk of at least 1 long-COVID symptom was 25.0 per 100 cases (95% confidence interval [CI], 22.2-27.4). Compared to controls, cases reported worse general health (OR, 5.9 [95% CI, 5.0-7.0]) and had higher odds for a broad range of symptoms, particularly loss of taste (OR, 11.8 [95% CI, 9.5-14.6]) and smell (OR, 11.2 [95% CI, 9.1-13.9]). Physical and Mental Component Summary scores were also significantly reduced with differences of -2.5 (95% CI, -3.1 to -1.8) and -2.0 (95% CI, -2.7 to -1.2), respectively. Female sex and severity of initial infection were major risk factors for long COVID.

Conclusions:

Nonhospitalized SARS-CoV-2 PCR-positive individuals had significantly reduced physical and mental health, and 1 in 4 reported persistence of at least 1 long-COVID symptom.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Language: English Journal: Open Forum Infect Dis Year: 2023 Document Type: Article Affiliation country: Ofid

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Language: English Journal: Open Forum Infect Dis Year: 2023 Document Type: Article Affiliation country: Ofid